Benjamin T. Sporn
Algemeen Adviseur bij NXXI, Inc.
Profiel
Benjamin T.
Sporn is currently working as the Secretary, Vice President & General Counsel at NXXI, Inc. He previously worked as a Secretary at Chiasma, Inc. Mr. Sporn has a graduate degree from American University and an undergraduate degree from Rensselaer Polytechnic Institute.
Actieve functies van Benjamin T. Sporn
| Bedrijven | Functie | Begin |
|---|---|---|
NXXI, Inc.
 NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Algemeen Adviseur | 14-06-2010 |
Eerdere bekende functies van Benjamin T. Sporn
| Bedrijven | Functie | Einde |
|---|---|---|
| CHIASMA, INC. | Bedrijfssecretaris | - |
Opleiding van Benjamin T. Sporn
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| American University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Newton Center, MA. | Health Technology |
